Back to Results
First PageMeta Content
Prodrugs / Busulfan / 1 / 4-Butanediol / Carcinogen / International Agency for Research on Cancer / Hazardous drugs / Chemotherapy / Nitrosamine / Medicine / Oncology / Sedatives


1,4-Butanediol Dimethanesulfonate
Add to Reading List

Document Date: 2014-10-02 09:28:05

Open Document

File Size: 74,62 KB

Share Result on Facebook

City

Lyon / /

Company

Otsuka Pharmaceutical Co. Ltd. / GlaxoSmithKline LLC / SRI Consulting / /

Country

France / United States / /

Facility

National Library of Medicine / University of Akron / Guidelines National Institute / National Institute / /

IndustryTerm

Internet Drug Index / pharmaceutical / drug products / aqueous solution / /

MarketIndex

Internet Drug / /

MedicalCondition

leukemia / tumor / Cancer / tumors / particularly chronic myelocytic leukemia / pulmonary lesions / benign tumors / chronic myelogenous leukemia / ovarian tumors / thymic lymphoma / T-cell lymphoma / /

MedicalTreatment

bone marrow transplants / bone-marrow transplant / radiation / /

Organization

U.S. Food and Drug Administration / Department of Health and Human Services Exposure Patients / Guidelines National Institute for Occupational Safety and Health / University of Akron / Consumer Product Safety Commission / National Institute for Occupational Safety and Health / Occupational Safety and Health Administration / Department of Chemistry / International Agency for Research / /

Person

Butanediol Dimethanesulphonate / /

Position

producer / /

Product

Myleran / cyclophosphamide / Busulfex / /

Technology

radiation / http / html / /

URL

http /

SocialTag